This paper is in the following e-collection/theme issue:

Reviews on Public Health Technology and Innovation (86) Pharmacovigilance (171) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (215) Pharmacology and Pharmaceutics (111)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/63808, first published .
Estimating Adverse Events Associated With Herbal Medicines Using Pharmacovigilance Databases: Systematic Review and Meta-Analysis

Estimating Adverse Events Associated With Herbal Medicines Using Pharmacovigilance Databases: Systematic Review and Meta-Analysis

Estimating Adverse Events Associated With Herbal Medicines Using Pharmacovigilance Databases: Systematic Review and Meta-Analysis

Authors of this article:

Chuenjid Kongkaew1, 2 Author Orcid Image ;   Dang Thuc Anh Phan1, 3 Author Orcid Image ;   Prathan Janusorn1, 4 Author Orcid Image ;   Pajaree Mongkhon1, 5 Author Orcid Image
Article Authors Cited by (8) Tweetations (2) Metrics Author Video

Journals

  1. Phan D, Kongkaew C, Heinrich M, Dao T, Vo T. From ‘traditional’ remedies to ‘modern’ supplements: a systematic review and meta-analysis of pharmaceutical adulteration in weight-loss natural products. Frontiers in Pharmacology 2025;16 View
  2. Sartori D, Aronson J, Brand J, Gauffin O, Hedfors Vidlin S, Norén G, Onakpoya I. Signals of Adverse Reactions to Herbal Medicines: Evidence and Document Analysis Based on a Scoping Review. Drug Safety 2025;48(12):1339 View
  3. Kim S, Park M, Cho E, Cha J, Yang C, Kim S. Herbal medicine evaluation for reimbursement-based facial palsy (HERB-FP): a retrospective analysis using Korean health insurance claim data 2020–2024. BMC Complementary Medicine and Therapies 2025;25(1) View
  4. Rao P. Natural products and nutraceuticals in the management of chronic inflammatory diseases: efficacy, mechanisms, and comparative insights. Inflammopharmacology 2025;33(10):5777 View
  5. Spanakis M, Bakaros E, Papadopoulou S, Fournaraki A, Symvoulakis E. Pharmacoepidemiological Data on Drug–Herb Interactions: Serotonin Syndrome, Arrhythmias and the Emerging Role of Artificial Intelligence. Pharmacoepidemiology 2025;4(4):22 View
  6. Khan M, Khalid M, Malik O. The safety of herbal medicines in low- and middle-income countries (LMICs): current landscape and promoting the pharmacovigilance practices. Journal of Pharmaceutical Policy and Practice 2025;18(1) View
  7. M. S, Puthiyedath R, Pillai Z. Drug–herb interactions: a challenge and clinical concern in primary healthcare. Frontiers in Medicine 2025;12 View
  8. De la Garza Salazar F. From Interaction to Intervention: Intentional CYP Inhibition as a Scalable Strategy to Expand Access to High-Cost Therapies. European Journal of Drug Metabolism and Pharmacokinetics 2025 View